|
Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: (18F)fluorodeoxyglucose PET and CT comparison |
Mansueto M, Grimaldi A, Torbica A, Pepe G, Giovacchini G, Messa C, Fazio F |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Mansueto M, Grimaldi A, Torbica A, Pepe G, Giovacchini G, Messa C, Fazio F. Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: (18F)fluorodeoxyglucose PET and CT comparison. Quarterly Journal of Nuclear Medicine and Molecular Imaging 2007; 51(3): 224-234 Indexing Status Subject indexing assigned by NLM MeSH Cost-Benefit Analysis /economics /statistics & Female; Fluorodeoxyglucose F18 /economics; Health Care Costs /statistics & Humans; Italy /epidemiology; Lung Neoplasms /diagnosis /economics /mortality; Male; Positron-Emission Tomography /economics /statistics & Radiopharmaceuticals /economics; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed /economics /statistics & numerical data; numerical data; numerical data; numerical data AccessionNumber 22007002119 Date bibliographic record published 12/10/2007 |
|
|
|